FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130253344> ?p ?o ?g. }

• W2130253344 endingPage "3158" @default.
• W2130253344 startingPage "3146" @default.
• W2130253344 abstract "Malignant peripheral nerve sheath tumor (MPNST) is a highly aggressive tumor type that is resistant to chemotherapy and there are no effective therapies. MPNSTs have been shown to have gene amplification for receptor tyrosine kinases (RTK), PDGFR and c-Kit. We tested the c-Kit inhibitor, imatinib, and PLX3397, a selective c-Fms and c-Kit inhibitor, to evaluate their efficacy against MPNST cells in vitro and in vivo.We tested the efficacy of imatinib or PLX3397 either alone or in combination with TORC1 inhibitor rapamycin in a cell proliferation assay in vitro and by immunoblotting to determine target inhibition. Immunoblotting and immunohistochemical analysis was further carried out using xenograft samples in vivo.Our in vitro studies show that imatinib and PLX3397 similarly inhibit cell growth and this can be enhanced with rapamycin with comparable target specificity. However, in vivo studies clearly demonstrate that compared with imatinib, PLX3397 results in sustained blockade of c-Kit, c-Fms, and PDGFRβ, resulting in significant suppression of tumor growth. Moreover, staining for Iba-1, a marker for macrophages, indicates that PLX3397 results in significant depletion of macrophages in the growing tumors. The combination of PLX3397 and rapamycin results in even greater macrophage depletion with continued growth suppression, even when the drug treatment is discontinued.Taken together, our data strongly suggest that PLX3397 is superior to imatinib in the treatment of MPNSTs, and the combination of PLX3397 with a TORC1 inhibitor could provide a new therapeutic approach for the treatment of this disease." @default.
• W2130253344 created "2016-06-24" @default.
• W2130253344 creator A5004111432 @default.
• W2130253344 creator A5006913373 @default.
• W2130253344 creator A5007697804 @default.
• W2130253344 creator A5021613626 @default.
• W2130253344 creator A5021772683 @default.
• W2130253344 creator A5031037291 @default.
• W2130253344 creator A5079178474 @default.
• W2130253344 date "2014-06-12" @default.
• W2130253344 modified "2023-10-14" @default.
• W2130253344 title "Sustained Inhibition of Receptor Tyrosine Kinases and Macrophage Depletion by PLX3397 and Rapamycin as a Potential New Approach for the Treatment of MPNSTs" @default.
• W2130253344 cites W1506672302 @default.
• W2130253344 cites W1971158504 @default.
• W2130253344 cites W1971337988 @default.
• W2130253344 cites W1971656848 @default.
• W2130253344 cites W1977435414 @default.
• W2130253344 cites W1984793163 @default.
• W2130253344 cites W1993442838 @default.
• W2130253344 cites W1996555514 @default.
• W2130253344 cites W2003908642 @default.
• W2130253344 cites W2011017763 @default.
• W2130253344 cites W2019179700 @default.
• W2130253344 cites W2030379493 @default.
• W2130253344 cites W2073355522 @default.
• W2130253344 cites W2077203214 @default.
• W2130253344 cites W2077813502 @default.
• W2130253344 cites W2079659068 @default.
• W2130253344 cites W2082755707 @default.
• W2130253344 cites W2093635574 @default.
• W2130253344 cites W2094033908 @default.
• W2130253344 cites W2096986655 @default.
• W2130253344 cites W2100516555 @default.
• W2130253344 cites W2106027870 @default.
• W2130253344 cites W2121550925 @default.
• W2130253344 cites W2126783165 @default.
• W2130253344 cites W2127920954 @default.
• W2130253344 cites W2129314665 @default.
• W2130253344 cites W2130521145 @default.
• W2130253344 cites W2135174193 @default.
• W2130253344 cites W2137036286 @default.
• W2130253344 cites W2141332502 @default.
• W2130253344 cites W2142237270 @default.
• W2130253344 cites W2144972082 @default.
• W2130253344 cites W2145040145 @default.
• W2130253344 cites W2149500996 @default.
• W2130253344 cites W2151062731 @default.
• W2130253344 cites W2163035374 @default.
• W2130253344 cites W2165808734 @default.
• W2130253344 cites W2171144156 @default.
• W2130253344 cites W2171405465 @default.
• W2130253344 cites W2172156898 @default.
• W2130253344 cites W2183002501 @default.
• W2130253344 cites W2312282875 @default.
• W2130253344 cites W4241629386 @default.
• W2130253344 doi "https://doi.org/10.1158/1078-0432.ccr-13-2576" @default.
• W2130253344 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4060793" @default.
• W2130253344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24718867" @default.
• W2130253344 hasPublicationYear "2014" @default.
• W2130253344 type Work @default.
• W2130253344 sameAs 2130253344 @default.
• W2130253344 citedByCount "79" @default.
• W2130253344 countsByYear W21302533442015 @default.
• W2130253344 countsByYear W21302533442016 @default.
• W2130253344 countsByYear W21302533442017 @default.
• W2130253344 countsByYear W21302533442018 @default.
• W2130253344 countsByYear W21302533442019 @default.
• W2130253344 countsByYear W21302533442020 @default.
• W2130253344 countsByYear W21302533442021 @default.
• W2130253344 countsByYear W21302533442022 @default.
• W2130253344 countsByYear W21302533442023 @default.
• W2130253344 crossrefType "journal-article" @default.
• W2130253344 hasAuthorship W2130253344A5004111432 @default.
• W2130253344 hasAuthorship W2130253344A5006913373 @default.
• W2130253344 hasAuthorship W2130253344A5007697804 @default.
• W2130253344 hasAuthorship W2130253344A5021613626 @default.
• W2130253344 hasAuthorship W2130253344A5021772683 @default.
• W2130253344 hasAuthorship W2130253344A5031037291 @default.
• W2130253344 hasAuthorship W2130253344A5079178474 @default.
• W2130253344 hasBestOaLocation W21302533441 @default.
• W2130253344 hasConcept C121608353 @default.
• W2130253344 hasConcept C126322002 @default.
• W2130253344 hasConcept C150903083 @default.
• W2130253344 hasConcept C170493617 @default.
• W2130253344 hasConcept C185592680 @default.
• W2130253344 hasConcept C202751555 @default.
• W2130253344 hasConcept C207001950 @default.
• W2130253344 hasConcept C2777583451 @default.
• W2130253344 hasConcept C2778729363 @default.
• W2130253344 hasConcept C2778820342 @default.
• W2130253344 hasConcept C42362537 @default.
• W2130253344 hasConcept C502942594 @default.
• W2130253344 hasConcept C55493867 @default.
• W2130253344 hasConcept C71924100 @default.
• W2130253344 hasConcept C86803240 @default.
• W2130253344 hasConcept C98274493 @default.
• W2130253344 hasConceptScore W2130253344C121608353 @default.
• W2130253344 hasConceptScore W2130253344C126322002 @default.

• next